Clinical trial
Prometa Pharmacotherapy for Methamphetamine Dependence
NCT00260481 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00260481 |
|---|---|
| Title | Prometa Pharmacotherapy for Methamphetamine Dependence |
| Official title | Double-Blind, Placebo Controlled Trial of Prometa Pharmacotherapy for the Treatment of Methamphetamine Abuse |
| Lead sponsor | University of California, Los Angeles, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Drug Abuse, Drug Dependence |
| Intervention type | Drug |
| Interventions | Prometa, Placebo |
| Enrollment | 120 |
| Start date | Jan 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Dec 1, 2005 |
| Last update posted | Jan 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: